Atypical femoral fractures bilaterally in a patient receiving denosumab

Acta Orthopaedica

Volumn 85, Issue 1, 2014, Pages 3-5

  Drampalos, Efstathios ^a   Skarpas, George ^b   Barbounakis, Nikos ^b   Michos, Ioannis ^b  

^a BROOMFIELD HOSPITAL   (United Kingdom)

^b Asklipieion Voulas Hospital   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; DENOSUMAB; PARATHYROID HORMONE[1-34]; VITAMIN D;

AGED; BONE DENSITOMETRY; BONE NAIL; BONE RADIOGRAPHY; CASE REPORT; DRUG WITHDRAWAL; FEMALE; FEMUR SHAFT FRACTURE; HUMAN; POSTMENOPAUSE OSTEOPOROSIS; REVIEW;

AGED; ALENDRONATE; ANTIBODIES, MONOCLONAL, HUMANIZED; BONE DENSITY CONSERVATION AGENTS; DRUG ADMINISTRATION SCHEDULE; FEMALE; FEMORAL FRACTURES; FRACTURES, STRESS; HUMANS; OSTEOPOROSIS, POSTMENOPAUSAL; OSTEOPOROTIC FRACTURES;

EID: 84896889803     PISSN: 17453674     EISSN: 17453682     Source Type: Journal    
DOI: 10.3109/17453674.2013.854668     Document Type: Review

References (7)

1. Cummings S R, San Martin J, McClung M R, Siris E S, Eastell R, Reid I R, Delmas P, Zoog H B, Austin M, Wang A, Kutilek S, Adami S, Zancetta J, Libanati C, Siddhanti S, Christiansen C; FREEDOM Trial. Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N England J Med 2009; 361:756-65.
2. Kendler D, Roux C, Benhamou C, et al. Effects of denosumab on bone mineral density and bone turnover in postmenopausal women transitioning from alendronate therapy. J Bone Miner Res 2010; 25: 72-81.
3. Langdahl B L, Rajzbaum G, Karras F J D, Ljunggren Ö, Lems W F, Fahrleitner-Pammer A, Walsh J B, Barker C, Kutahov A, Marin F. Reduction in fracture rate and back pain and increased quality of life in postmenopausal women treated with teriparatide: 18-month data from the European Forsteo Observational Study (EFOS). Calcif Tissue Int 2009; 85 (6): 484-93.
4. Neviaser A S, Lane J M, Lenart B A, Edobor-Osula F, Lorich D G. Lowenergy femoral shaft fractures associated with alendronate use. J Orthop Trauma 2008; 22: 346-50.
5. Paparodis R, Buehring B, Pelley E, Binkley N. A case of an unsusual subtrochanteric fracture in a patient receiving denosumab. Endocr Pract 2013; 21: 1-17. [Epub a head of print].
6. Schilcher J, Michaëlsson K, Aspenberg P. Bisphosphonate use and atypical fractures of the femoral shaft. N Engl J Med 2011; 364 :1728-37.
7. Shane E, Burr D, Abrahamsen B et al. Atypical subtrochanteric and diaphyseal femoral fractures: Second report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 2013. doi: 10.1002/ jbmr.1998. [Epub ahead of print].